All News #Library
Quality
FDA Grants Priority Review to Vertex’s 1st Triple Combo for CF
27 Aug 2019 //
CYSTICFIBROSISNEWS TODAY
FDA slaps a clinical hold on sickle cell IND filed by Vertex & CRISPR
30 May 2018 //
ENDPTS
Respiratory drug may be withdrawn
09 Dec 2016 //
IRISH EXAMINER
FDA Staff Questions Value Of Vertex`s Cystic Fibrosis Combo
09 May 2015 //
REUTERS

Market Place
Sourcing Support